Lupin Fights EU's 'Wholly Novel' Pay-For-Delay Fine
Generic-drug maker Lupin Ltd. has appealed the European Commission's decision to fine it €40 million ($49 million) as part of the antitrust watchdog's pay-for-delay case against French pharmaceutical company Servier, saying...To view the full article, register now.
Already a subscriber? Click here to view full article